Back to Journals » Biologics: Targets and Therapy » Volume 8

Resistant mutations in CML and Ph+ALL – role of ponatinib

Total article views   HTML views PDF downloads Totals
32,897 Dovepress* 22,964+ 3,021 25,985
PubMed Central* 9,933 2,090 12,023
Totals 32,897 5,111 38,008
*Since 20 October 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 0 0 4

View citations on PubMed Central and Google Scholar